The Valley Desk

NCT04023552 · Interventional trial

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Overall registry status Completed

Phase 3

Conditions Cardiovascular Disease and Lipoprotein(a)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov